4231 - 4240 of 7915 Results
Title
Year
- Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch2020OPENTitle: Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-BranchJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 6Start Page: 1442End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9061442Best OA location URL: https://www.mdpi.com/2073-4409/9/6/1442/pdf?version=1592474637Citation Count: 17
- Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?2020OPENTitle: Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 9Start Page: 1618End Page: 1625Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28115Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28115Citation Count: 42
-
OPENTitle: Clinical Progression of Parkinson’s Disease: Insights from the NINDS Common Data ElementsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1075End Page: 1085Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201932Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177750Citation Count: 20
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
- “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation2020OPENTitle: “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial ParticipationJournal Name: AJOB Empirical BioethicsPublisher: Informa UK LimitedVol: 11Issue #: 3Start Page: 160End Page: 171Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/23294515.2020.1775721Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212889Citation Count: 5
- Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease2020OPENTitle: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66319-9Best OA location URL: https://www.nature.com/articles/s41598-020-66319-9.pdfCitation Count: 20
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020OPENTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 14Issue #: 6Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866Best OA location URL: https://ndownloader.figstatic.com/files/22969427Citation Count: 10
- Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations2020OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://manuscript.elsevier.com/S1353802020300973/pdf/S1353802020300973.pdfCitation Count: 37
-
OPENTitle: Sex Disparities in Autonomic Symptom Treatment in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 718End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12997Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12997Citation Count: 5